Lankeit, Mareike

[["dc.bibliographiccitation.firstpage","1402"],["dc.bibliographiccitation.issue","15"],["dc.bibliographiccitation.journal","New England Journal of Medicine"],["dc.bibliographiccitation.lastpage","1411"],["dc.bibliographiccitation.volume","370"],["dc.contributor.author","Meyer, Guy"],["dc.contributor.author","Vicaut, Eric"],["dc.contributor.author","Danays, Thierry"],["dc.contributor.author","Agnelli, Giancarlo"],["dc.contributor.author","Becattini, Cecilia"],["dc.contributor.author","Beyer-Westendorf, Jan"],["dc.contributor.author","Bluhmki, Erich"],["dc.contributor.author","Bouvaist, Helene"],["dc.contributor.author","Brenner, Benjamin"],["dc.contributor.author","Couturaud, Francis"],["dc.contributor.author","Dellas, Claudia"],["dc.contributor.author","Empen, Klaus"],["dc.contributor.author","Franca, Ana"],["dc.contributor.author","Galie, Nazzareno"],["dc.contributor.author","Geibel, Annette"],["dc.contributor.author","Goldhaber, Samuel Z."],["dc.contributor.author","Jimenez, David"],["dc.contributor.author","Kozak, Matija"],["dc.contributor.author","Kupatt, Christian"],["dc.contributor.author","Kucher, Nils"],["dc.contributor.author","Lang, Irene M."],["dc.contributor.author","Lankeit, Mareike K."],["dc.contributor.author","Meneveau, Nicolas"],["dc.contributor.author","Pacouret, Gerard"],["dc.contributor.author","Palazzini, Massimiliano"],["dc.contributor.author","Petris, Antoniu"],["dc.contributor.author","Pruszczyk, Piotr"],["dc.contributor.author","Rugolotto, Matteo"],["dc.contributor.author","Salvi, Aldo"],["dc.contributor.author","Schellong, Sebastian"],["dc.contributor.author","Sebbane, Mustapha"],["dc.contributor.author","Sobkowicz, Bozena"],["dc.contributor.author","Stefanovic, Branislav S."],["dc.contributor.author","Thiele, Holger"],["dc.contributor.author","Torbicki, Adam"],["dc.contributor.author","Verschuren, Franck"],["dc.contributor.author","Konstantinides, Stavros V."],["dc.date.accessioned","2018-11-07T09:41:18Z"],["dc.date.available","2018-11-07T09:41:18Z"],["dc.date.issued","2014"],["dc.description.abstract","BackgroundThe role of fibrinolytic therapy in patients with intermediate-risk pulmonary embolism is controversial. MethodsIn a randomized, double-blind trial, we compared tenecteplase plus heparin with placebo plus heparin in normotensive patients with intermediate-risk pulmonary embolism. Eligible patients had right ventricular dysfunction on echocardiography or computed tomography, as well as myocardial injury as indicated by a positive test for cardiac troponin I or troponin T. The primary outcome was death or hemodynamic decompensation (or collapse) within 7 days after randomization. The main safety outcomes were major extracranial bleeding and ischemic or hemorrhagic stroke within 7 days after randomization. ResultsOf 1006 patients who underwent randomization, 1005 were included in the intention-to-treat analysis. Death or hemodynamic decompensation occurred in 13 of 506 patients (2.6%) in the tenecteplase group as compared with 28 of 499 (5.6%) in the placebo group (odds ratio, 0.44; 95% confidence interval, 0.23 to 0.87; P=0.02). Between randomization and day 7, a total of 6 patients (1.2%) in the tenecteplase group and 9 (1.8%) in the placebo group died (P=0.42). Extracranial bleeding occurred in 32 patients (6.3%) in the tenecteplase group and 6 patients (1.2%) in the placebo group (P<0.001). Stroke occurred in 12 patients (2.4%) in the tenecteplase group and was hemorrhagic in 10 patients; 1 patient (0.2%) in the placebo group had a stroke, which was hemorrhagic (P=0.003). By day 30, a total of 12 patients (2.4%) in the tenecteplase group and 16 patients (3.2%) in the placebo group had died (P=0.42). ConclusionsIn patients with intermediate-risk pulmonary embolism, fibrinolytic therapy prevented hemodynamic decompensation but increased the risk of major hemorrhage and stroke. (Funded by the Programme Hospitalier de Recherche Clinique in France and others; PEITHO EudraCT number, 2006-005328-18; ClinicalTrials.gov number, NCT00639743.) In a randomized trial, 1006 patients with intermediate-risk pulmonary embolism were assigned to tenecteplase or placebo in addition to standard heparin therapy. The tenecteplase group had a lower rate of hemodynamic decompensation but more frequent major hemorrhage and stroke. Acute pulmonary embolism occurs frequently and may cause death or serious disability.(1) Case fatality rates vary widely,(2),(3) but approximately 10% of all patients with acute pulmonary embolism die within 3 months after the diagnosis.(4),(5) Acute right ventricular pressure overload at diagnosis is an important determinant of the severity and early clinical outcome of pulmonary embolism.(6) High-risk pulmonary embolism(7) is characterized by overt hemodynamic instability and warrants immediate advanced therapy, including consideration of fibrinolysis. In contrast, for patients presenting without systemic hypotension or hemodynamic compromise, standard anticoagulation is generally considered adequate treatment.(8) However, patients who have acute right ventricular ..."],["dc.identifier.doi","10.1056/NEJMoa1302097"],["dc.identifier.isi","000334095200008"],["dc.identifier.pmid","24716681"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/33698"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Massachusetts Medical Soc"],["dc.relation.issn","1533-4406"],["dc.relation.issn","0028-4793"],["dc.title","Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1536"],["dc.bibliographiccitation.issue","12"],["dc.bibliographiccitation.journal","Journal of the American College of Cardiology"],["dc.bibliographiccitation.lastpage","1544"],["dc.bibliographiccitation.volume","69"],["dc.contributor.author","Konstantinides, Stavros V."],["dc.contributor.author","Vicaut, Eric"],["dc.contributor.author","Danays, Thierry"],["dc.contributor.author","Becattini, Cecilia"],["dc.contributor.author","Bertoletti, Laurent"],["dc.contributor.author","Beyer-Westendorf, Jan"],["dc.contributor.author","Bouvaist, Helene"],["dc.contributor.author","Couturaud, Francis"],["dc.contributor.author","Dellas, Claudia"],["dc.contributor.author","Duerschmied, Daniel"],["dc.contributor.author","Empen, Klaus"],["dc.contributor.author","Ferrari, Emile"],["dc.contributor.author","Galie, Nazzareno"],["dc.contributor.author","Jimenez, David"],["dc.contributor.author","Kostrubiec, Maciej"],["dc.contributor.author","Kozak, Matija"],["dc.contributor.author","Kupatt, Christian"],["dc.contributor.author","Lang, Irene M."],["dc.contributor.author","Lankeit, Mareike K."],["dc.contributor.author","Meneveau, Nicolas"],["dc.contributor.author","Palazzini, Massimiliano"],["dc.contributor.author","Pruszczyk, Piotr"],["dc.contributor.author","Rugolotto, Matteo"],["dc.contributor.author","Salvi, Aldo"],["dc.contributor.author","Sanchez, Olivier"],["dc.contributor.author","Schellong, Sebastian"],["dc.contributor.author","Sobkowicz, Bozena"],["dc.contributor.author","Meyer, Guy"],["dc.date.accessioned","2018-11-07T10:26:01Z"],["dc.date.available","2018-11-07T10:26:01Z"],["dc.date.issued","2017"],["dc.description.abstract","BACKGROUND The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is unknown. OBJECTIVES This study investigated the long-term prognosis of patients with intermediate-risk PE and the effect of thrombolytic treatment on the persistence of symptoms or the development of late complications. METHODS The PEITHO (Pulmonary Embolism Thrombolysis) trial was a randomized (1: 1) comparison of thrombolysis with tenecteplase versus placebo in normotensive patients with acute PE, right ventricular (RV) dysfunction on imaging, and a positive cardiac troponin test result. Both treatment arms received standard anticoagulation. Long-term follow-up was included in the third protocol amendment; 28 sites randomizing 709 of the 1,006 patients participated. RESULTS Long-term (median 37.8 months) survival was assessed in 353 of 359 (98.3%) patients in the thrombolysis arm and in 343 of 350 (98.0%) in the placebo arm. Overall mortality rates were 20.3% and 18.0%, respectively (p = 0.43). Between day 30 and long-term follow-up, 65 deaths occurred in the thrombolysis arm and 53 occurred in the placebo arm. At follow-up examination of survivors, persistent dyspnea (mostly mild) or functional limitation was reported by 36.0% versus 30.1% of the patients (p = 0.23). Echocardiography (performed in 144 and 146 patients randomized to thrombolysis and placebo, respectively) did not reveal significant differences in residual pulmonary hypertension or RV dysfunction. Chronic thromboembolic pulmonary hypertension (CTEPH) was confirmed in 4 (2.1%) versus 6 (3.2%) cases (p = 0.79). CONCLUSIONS Approximately 33% of patients report some degree of persistent functional limitation after intermediate-risk PE, but CTEPH is infrequent. Thrombolytic treatment did not affect long-term mortality rates, and it did not appear to reduce residual dyspnea or RV dysfunction in these patients. (Pulmonary Embolism Thrombolysis study [PEITHO]; NCT00639743) (C) 2017 by the American College of Cardiology Foundation."],["dc.identifier.doi","10.1016/j.jacc.2016.12.039"],["dc.identifier.isi","000396730200003"],["dc.identifier.pmid","28335835"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/42961"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","PUB_WoS_Import"],["dc.publisher","Elsevier Science Inc"],["dc.relation.issn","1558-3597"],["dc.relation.issn","0735-1097"],["dc.title","Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","4186"],["dc.bibliographiccitation.issue","47"],["dc.bibliographiccitation.journal","European Heart Journal"],["dc.bibliographiccitation.lastpage","4195"],["dc.bibliographiccitation.volume","39"],["dc.contributor.author","Barco, Stefano"],["dc.contributor.author","Ende-Verhaar, Yvonne M"],["dc.contributor.author","Becattini, Cecilia"],["dc.contributor.author","Jimenez, David"],["dc.contributor.author","Lankeit, Mareike"],["dc.contributor.author","Huisman, Menno V"],["dc.contributor.author","Konstantinides, Stavros V"],["dc.contributor.author","Klok, Frederikus A"],["dc.date.accessioned","2020-12-10T18:19:03Z"],["dc.date.available","2020-12-10T18:19:03Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1093/eurheartj/ehy631"],["dc.identifier.eissn","1522-9645"],["dc.identifier.issn","0195-668X"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/75123"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","76"],["dc.bibliographiccitation.journal","European Journal of Internal Medicine"],["dc.bibliographiccitation.lastpage","82"],["dc.bibliographiccitation.volume","82"],["dc.contributor.author","Hobohm, Lukas"],["dc.contributor.author","Becattini, Cecilia"],["dc.contributor.author","Ebner, Matthias"],["dc.contributor.author","Lerchbaumer, Markus H."],["dc.contributor.author","Casazza, Franco"],["dc.contributor.author","Hasenfuß, Gerd"],["dc.contributor.author","Konstantinides, Stavros V."],["dc.contributor.author","Lankeit, Mareike"],["dc.date.accessioned","2021-04-14T08:29:42Z"],["dc.date.available","2021-04-14T08:29:42Z"],["dc.date.issued","2020"],["dc.identifier.doi","10.1016/j.ejim.2020.08.009"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/82966"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.issn","0953-6205"],["dc.title","Definition of tachycardia for risk stratification of pulmonary embolism"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1657"],["dc.bibliographiccitation.issue","13"],["dc.bibliographiccitation.journal","European Heart Journal"],["dc.bibliographiccitation.lastpage","1663"],["dc.bibliographiccitation.volume","32"],["dc.contributor.author","Becattini, Cecilia"],["dc.contributor.author","Agnelli, Giancarlo"],["dc.contributor.author","Vedovati, Maria Cristina"],["dc.contributor.author","Pruszczyk, Piotr"],["dc.contributor.author","Casazza, Franco"],["dc.contributor.author","Grifoni, Stefano"],["dc.contributor.author","Salvi, Aldo"],["dc.contributor.author","Bianchi, Marina"],["dc.contributor.author","Douma, Renee"],["dc.contributor.author","Konstantinides, Stavros V."],["dc.contributor.author","Lankeit, Mareike K."],["dc.contributor.author","Duranti, Michele"],["dc.date.accessioned","2018-11-07T08:54:25Z"],["dc.date.available","2018-11-07T08:54:25Z"],["dc.date.issued","2011"],["dc.description.abstract","Aims In patients with acute pulmonary embolism (PE), right ventricular dysfunction at echocardiography is associated with increased in-hospital mortality. The aims of this study in patients with acute PE were to identify a sensitive and simple criterion for right ventricular dysfunction at multidetector computed tomography (MDCT) using echocardiography as the reference standard and to evaluate the predictive value of the identified MDCT criterion for in-hospital death or clinical deterioration. Methods and results Right ventricular dysfunction at MDCT was defined as the right-to-left ventricular dimensional ratio and was centrally assessed by a panel unaware of clinical and echocardiographic data. A right-to-left ventricular dimensional ratio >= 0.9 at MDCT had a 92% sensitivity for right ventricular dysfunction [95% confidence interval (CI) 88-96]. Overall, 457 patients were included in the outcome study: 303 had right ventricular dysfunction at MDCT. In-hospital death or clinical deterioration occurred in 44 patients with and in 8 patients without right ventricular dysfunction at MDCT (14.5 vs. 5.2%; P < 0.004). The negative predictive value of right ventricular dysfunction for death due to PE was 100% (95% CI 98-100). Right ventricular dysfunction at MDCT was an independent predictor for in-hospital death or clinical deterioration in the overall population [hazard ratio (HR) 3.5, 95% CI 1.6-7.7; P = 0.002] and in haemodynamically stable patients (HR 3.8, 95% CI 1.3-10.9; P = 0.007). Conclusion In patients with acute PE, MDCT might be used as a single procedure for diagnosis and risk stratification. Patients without right ventricular dysfunction at MDCT have a low risk of in-hospital adverse outcome."],["dc.identifier.doi","10.1093/eurheartj/ehr108"],["dc.identifier.isi","000295679200017"],["dc.identifier.pmid","21504936"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/22663"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Oxford Univ Press"],["dc.relation.issn","0195-668X"],["dc.title","Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.journal","Clinical Research in Cardiology"],["dc.contributor.author","Barco, Stefano"],["dc.contributor.author","Russo, Mariaconcetta"],["dc.contributor.author","Vicaut, Eric"],["dc.contributor.author","Becattini, Cecilia"],["dc.contributor.author","Bertoletti, Laurent"],["dc.contributor.author","Beyer-Westendorf, Jan"],["dc.contributor.author","Bouvaist, Hélène"],["dc.contributor.author","Couturaud, Francis"],["dc.contributor.author","Danays, Thierry"],["dc.contributor.author","Dellas, Claudia"],["dc.contributor.author","Duerschmied, Daniel"],["dc.contributor.author","Empen, Klaus"],["dc.contributor.author","Ferrari, Emile"],["dc.contributor.author","Galiè, Nazzareno"],["dc.contributor.author","Jiménez, David"],["dc.contributor.author","Klok, Frederikus A."],["dc.contributor.author","Kostrubiec, Maciej"],["dc.contributor.author","Kozak, Matija"],["dc.contributor.author","Kupatt, Christian"],["dc.contributor.author","Lang, Irene M."],["dc.contributor.author","Lankeit, Mareike"],["dc.contributor.author","Meneveau, Nicolas"],["dc.contributor.author","Palazzini, Massimiliano"],["dc.contributor.author","Pruszczyk, Piotr"],["dc.contributor.author","Rugolotto, Matteo"],["dc.contributor.author","Salvi, Aldo"],["dc.contributor.author","Sanchez, Olivier"],["dc.contributor.author","Schellong, Sebastian"],["dc.contributor.author","Sobkowicz, Bozena"],["dc.contributor.author","Meyer, Guy"],["dc.contributor.author","Konstantinides, Stavros V."],["dc.date.accessioned","2019-07-09T11:51:00Z"],["dc.date.available","2019-07-09T11:51:00Z"],["dc.date.issued","2018"],["dc.description.abstract","INTRODUCTION: Symptoms and functional limitation are frequently reported by survivors of acute pulmonary embolism (PE). However, current guidelines provide no specific recommendations on which patients should be followed after acute PE, when follow-up should be performed, and which tests it should include. Definition and classification of late PE sequelae are evolving, and their predictors remain to be determined. METHODS: In a post hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial, we focused on 219 survivors of acute intermediate-risk PE with clinical and echocardiographic follow-up 6 months after randomisation as well as over the long term (median, 3 years after acute PE). The primary outcome was a composite of (1) confirmed chronic thromboembolic pulmonary hypertension (CTEPH) or (2) 'post-PE impairment' (PPEI), defined by echocardiographic findings indicating an intermediate or high probability of pulmonary hypertension along with New York Heart Association functional class II-IV. RESULTS: Confirmed CTEPH or PPEI occurred in 29 (13.2%) patients, (6 with CTEPH and 23 with PPEI). A history of chronic heart failure at baseline and incomplete or absent recovery of echocardiographic parameters at 6 months predicted CTEPH or PPEI at long-term follow-up. CONCLUSIONS: CTEPH or PPEI occurs in almost one out of seven patients after acute intermediate-risk PE. Six-month echocardiographic follow-up may be useful for timely detection of late sequelae."],["dc.identifier.doi","10.1007/s00392-018-1405-1"],["dc.identifier.pmid","30564950"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/16028"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/59856"],["dc.language.iso","en"],["dc.notes.intern","Merged from goescholar"],["dc.relation.issn","1861-0692"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.subject.ddc","610"],["dc.title","Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1901647"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","European Respiratory Journal"],["dc.bibliographiccitation.volume","54"],["dc.contributor.author","Konstantinides, Stavros V."],["dc.contributor.author","Meyer, Guy"],["dc.contributor.author","Becattini, Cecilia"],["dc.contributor.author","Bueno, Héctor"],["dc.contributor.author","Geersing, Geert-Jan"],["dc.contributor.author","Harjola, Veli-Pekka"],["dc.contributor.author","Huisman, Menno V."],["dc.contributor.author","Humbert, Marc"],["dc.contributor.author","Jennings, Catriona Sian"],["dc.contributor.author","Jiménez, David"],["dc.contributor.author","Kucher, Nils"],["dc.contributor.author","Lang, Irene Marthe"],["dc.contributor.author","Lankeit, Mareike"],["dc.contributor.author","Lorusso, Roberto"],["dc.contributor.author","Mazzolai, Lucia"],["dc.contributor.author","Meneveau, Nicolas"],["dc.contributor.author","Áinle, Fionnuala Ní"],["dc.contributor.author","Prandoni, Paolo"],["dc.contributor.author","Pruszczyk, Piotr"],["dc.contributor.author","Righini, Marc"],["dc.contributor.author","Torbicki, Adam"],["dc.contributor.author","Van Belle, Eric"],["dc.contributor.author","Zamorano, José Luis"],["dc.date.accessioned","2020-12-10T18:38:49Z"],["dc.date.available","2020-12-10T18:38:49Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1183/13993003.01647-2019"],["dc.identifier.eissn","1399-3003"],["dc.identifier.issn","0903-1936"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77443"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)"],["dc.title.alternative","The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","2002368"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","European Respiratory Journal"],["dc.bibliographiccitation.volume","57"],["dc.contributor.author","Barco, Stefano"],["dc.contributor.author","Schmidtmann, Irene"],["dc.contributor.author","Ageno, Walter"],["dc.contributor.author","Anušić, Toni"],["dc.contributor.author","Bauersachs, Rupert M."],["dc.contributor.author","Becattini, Cecilia"],["dc.contributor.author","Bernardi, Enrico"],["dc.contributor.author","Beyer-Westendorf, Jan"],["dc.contributor.author","Bonacchini, Luca"],["dc.contributor.author","Brachmann, Johannes"],["dc.contributor.author","Christ, Michael"],["dc.contributor.author","Czihal, Michael"],["dc.contributor.author","Duerschmied, Daniel"],["dc.contributor.author","Empen, Klaus"],["dc.contributor.author","Espinola-Klein, Christine"],["dc.contributor.author","Ficker, Joachim H."],["dc.contributor.author","Fonseca, Cândida"],["dc.contributor.author","Genth-Zotz, Sabine"],["dc.contributor.author","Jiménez, David"],["dc.contributor.author","Harjola, Veli-Pekka"],["dc.contributor.author","Held, Matthias"],["dc.contributor.author","Iogna Prat, Lorenzo"],["dc.contributor.author","Lange, Tobias J."],["dc.contributor.author","Lankeit, Mareike"],["dc.contributor.author","Manolis, Athanasios"],["dc.contributor.author","Meyer, Andreas"],["dc.contributor.author","Münzel, Thomas"],["dc.contributor.author","Mustonen, Pirjo"],["dc.contributor.author","Rauch-Kroehnert, Ursula"],["dc.contributor.author","Ruiz-Artacho, Pedro"],["dc.contributor.author","Schellong, Sebastian"],["dc.contributor.author","Schwaiblmair, Martin"],["dc.contributor.author","Stahrenberg, Raoul"],["dc.contributor.author","Valerio, Luca"],["dc.contributor.author","Westerweel, Peter E."],["dc.contributor.author","Wild, Philipp S."],["dc.contributor.author","Konstantinides, Stavros V."],["dc.date.accessioned","2021-04-14T08:29:57Z"],["dc.date.available","2021-04-14T08:29:57Z"],["dc.date.issued","2021"],["dc.identifier.doi","10.1183/13993003.02368-2020"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/83044"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.eissn","1399-3003"],["dc.relation.issn","0903-1936"],["dc.title","Survival and quality of life after early discharge in low-risk pulmonary embolism"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]